Position in RCEL
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$156,839
+$12,071 QoQ
Shares Held
42,389
+1.0% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Nuveen, LLC holds $3,829,820,829 across 80 Medical Devices names. RCEL ranks #75 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
11,191,853 | $1,149,067,545 | |
| 2 | BSX |
Boston Scientific Corp
|
11,734,314 | $736,328,203 | |
| 3 | SYK |
Stryker Corp
|
1,638,048 | $538,246,191 | |
| 4 | MDT |
Medtronic plc
|
3,490,168 | $302,423,056 | |
| 5 | EW |
Edwards Lifesciences Corp
|
2,893,244 | $231,690,978 | |
| 6 | DXCM |
Dexcom Inc
|
1,724,467 | $108,296,526 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
999,912 | $90,412,041 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
1,212,548 | $86,309,165 |
All Filings in RCEL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $156,839 | 42,389 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $144,768 | 41,962 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $214,425 | 41,962 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $313,781 | 59,316 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $583,947 | 71,738 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||